老年社区获得性肺炎住院患者遵循指南抗生素治疗与出院后1年全因及心血管死亡率的关系
该研究纳入2004至2015年间在加拿大安大略省渥太华医院因社区获得性肺炎(CAP)住院并存活出院的1909例65岁以上老年患者,分析初始抗生素选择是否符合现行临床实践指南,并链接医院与省级数据库随访1年。调整患者1年预期死亡风险、CAP严重度及既往肺炎住院、心肌梗死、心力衰竭或脑血管病史后,遵循指南治疗与1年全因死亡呈下降趋势(HR 0.82;95%CI 0.65-1.04;P=0.099),与1年心血管死亡风险显著降低近50%相关(HR 0.53;95%CI 0.34-0.80;P=0.003)。作者认为该结果进一步支持现行CAP治疗指南推荐。
要点
- 老年CAP住院存活出院患者中,遵循指南的初始抗生素治疗与1年心血管死亡风险显著降低相关(HR 0.53;95%CI 0.34-0.80;P=0.003)。
- 同一人群中,遵循指南治疗与1年全因死亡呈下降趋势但未达统计学显著(HR 0.82;95%CI 0.65-1.04;P=0.099)。
- 研究纳入1909例>65岁于2004至2015年在渥太华医院因CAP住院并存活出院者,随访至出院后1年。
- 分析已调整患者1年预期死亡风险、CAP严重度及既往肺炎住院、心肌梗死、心力衰竭或脑血管病史。
- 作者认为该发现进一步支持现行临床实践指南对CAP治疗的推荐。
适用人群与场景
- >65岁、因社区获得性肺炎(CAP)在加拿大安大略省渥太华医院住院并存活出院的老年患者,纳入时间为2004至2015年,共1909例。
研究设计与关键结果
- 研究类型为在渥太华医院开展的研究,纳入1909例>65岁CAP住院存活出院患者,分析初始抗生素治疗是否符合现行临床实践指南,并链接医院与省级数据库随访1年。
- 调整患者1年预期死亡风险、CAP严重度及既往肺炎住院、心肌梗死、心力衰竭或脑血管病史后,遵循指南抗生素治疗与1年全因死亡呈下降趋势(HR 0.82;95%CI 0.65-1.04;P=0.099)。
- 遵循指南抗生素治疗与CAP入院后1年心血管死亡风险显著降低近50%相关(HR 0.53;95%CI 0.34-0.80;P=0.003)。
证据类型、等级与局限
- 证据类型:基于医院与省级数据库链接的观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,老年住院CAP患者使用遵循指南的抗生素治疗与1年心血管死亡风险显著降低相关,该发现进一步支持现行临床实践指南对CAP治疗的推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Selection of empiric antibiotic treatment for community-acquired pneumonia (CAP) that is concordant with clinical practice guidelines has been associated with improved short-term outcomes of this infection, but whether it is also associated with longer-term outcomes is unknown.
RESEARCH QUESTION: Is guideline-concordance of the initial antibiotic treatment given to older adult patients hospitalized with CAP associated with the 1-year all-cause and cardiovascular mortality risk of those patients who survive hospitalization for this infection?
STUDY DESIGN AND METHODS: A total of 1,909 older (> 65 years of age) patients were identified who survived hospitalization for CAP at The Ottawa Hospital (Ontario, Canada) between 2004 and 2015. Linking patients' information to hospital and provincial data sets, this study analyzed whether the selection of the initial antibiotic therapy for their CAP was concordant with current clinical practice guidelines, and whether guideline-concordance was associated with 1-year all-cause and cardiovascular mortality following their index CAP hospitalization. Adjustments were made for the patients' overall 1-year expected death risk; CAP severity; and history of previous pneumonia admissions, myocardial infarction, heart failure, or cerebrovascular disease.
RESULTS: Selection of guideline-concordant antibiotic therapy was associated with a trend towards lower all-cause mortality at 1 year post-CAP (hazard ratio, 0.82; 95% CI, 0.65-1.04; P = .099). Furthermore, the use of guideline-concordant antibiotic therapy was associated with a significant almost 50% reduction in cardiovascular death risk 1 year following CAP admission (hazard ratio, 0.53; 95% CI, 0.34-0.80; P = .003).
INTERPRETATION: Use of guideline-concordant antibiotic therapy for CAP treatment in older hospitalized patients is associated with a significant reduction in the risk of cardiovascular death at 1 year post-CAP. This finding further supports current clinical practice guideline recommendations for CAP treatment.
参考来源
- Corrales-Medina VF, van Walraven C. Guideline-Concordant Antibiotic Therapy for the Hospital Treatment of Community-Acquired Pneumonia and 1-Year All-Cause and Cardiovascular Mortality in Older Adult Patients Surviving to Discharge. Chest. 2023. PMID: 36621760. doi:10.1016/j.chest.2022.12.035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。